/
Farmmi Inc. is a global agricultural products supplier specializing in the production and distribution of a variety of edible fungi-derived products. Founded and headquartered in China, the company primarily focuses on cultivating and marketing mushrooms such as shiitake, mu erh, and other traditional Chinese varieties, along with bamboo fungi and other agricultural products. Farmmi Inc.'s business model emphasizes sustainable agricultural practices and leverages advanced cultivation technologies to enhance yield and product quality. The company caters to both domestic and international markets, providing raw and processed fungal foods to supermarkets, hypermarkets, online stores, and direct consumers. It plays a vital role in the food supply chain, particularly impacting sectors related to organic and healthy eating trends. Farmmi's operations are significant in promoting biodiversity, organic farming, and supporting rural economies. Its positioning in the market as a staple supplier of mushrooms underscores its importance within the agriculture industry, as it bridges traditional farming methods with modern distribution networks, ensuring consistent availability of high-quality agricultural products globally.
$0.19
+$0.00 (+0.00%)
EOD Jul 17, 2026
The business is unprofitable at the operating level (-168.88% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 56.4% YoY. Margins deteriorated 170.1pp alongside, both lines moving the wrong way.
ROIC dropped from 0.35% to -22.64%, capital efficiency is deteriorating. Operating margin contracted 170.1pp YoY, cost discipline may be slipping.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$28M
▼ -56.4% YoY
Net Income (TTM)
-$53M
▼ -1053.6% YoY
Op. Margin
-168.88%
▼ -170.1pp YoY
ROIC
-22.64%
▼ -23.0pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$52M
▲ +412.1% YoY
Op. Cash Flow (TTM)
$52M
▲ +544.3% YoY
Net Debt
$20M
Cash & Equiv.
$804K
3Y CAGR: -34.4%
3Y CAGR: +36.5%
Continue Research
Farmmi (FAMI) trades below a two-stage DCF intrinsic value of about $1,423.29 per share, so at $0.19 the stock looks undervalued (748,999.0% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Farmmi scores 39/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $1,423.29 per share for FAMI, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $1,067.47. At today's $0.19, that puts the stock about 748,999.0% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Farmmi scores 39 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -168.9% operating margin and a -22.6% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. FAMI currently trades below its estimated intrinsic value and scores 39/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.